Contents

Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers

An Unlikely Alliance – Could PBMs and diagnosis labs find synergies in the healthcare market?

The Challenges of Patenting Precision Medicine in the Era of Mayo and Myriad

Takeda using Advanced Machine Learning to find insights about NASH & TRD

Neurodegenerative diseases and the microbiome: lessons learned from mouse models

Precision Medicine In Complex Disease: Use Of The PrismRA Test To Stratify Patients For Response To Anti-Tnf Therapy In Rheumatoid Arthritis

Field Notes

The Global Market for Next Generation Sequencing Tests Continues Its Torrid Pace

An Unlikely Alliance – Could PBMs and diagnostic labs find synergies in the healthcare market?

Cognoscienti

Direct-to-Consumer Genetic Testing is Disrupting Our Healthcare System by Empowering Consumers

The Diagnostic Reimbursement System is Not Broken

Precision Tools

Enabling Genomics-Guided Precision Medicine with Real-World Evidence

Precision Medicine In Complex Disease: Use Of The PrismRA Test To Stratify Patients For Response To Anti-Tnf Therapy In Rheumatoid Arthritis

Breaking new ground in biomarker discovery: How SCIEX is pioneering the discovery of non-genetic biomarkers to adopt a holistic approach to precision medicine

Takeda using Advanced Machine Learning to find Insights about NASH & TRD

Snapshot
Neurodegenerative Diseases and the Microbiome: Lessons Learned from Mouse Models